Innovative Strategies for Hypoxic-Tumor Photodynamic Therapy

Angew Chem Int Ed Engl. 2018 Sep 3;57(36):11522-11531. doi: 10.1002/anie.201805138. Epub 2018 Aug 7.

Abstract

Despite its clinical promise, photodynamic therapy (PDT) suffers from a key drawback associated with its oxygen-dependent nature, which limits its effective use against hypoxic tumors. Moreover, both PDT-mediated oxygen consumption and microvascular damage further increase tumor hypoxia and, thus, impede therapeutic outcomes. In recent years, numerous investigations have focused on strategies for overcoming this drawback of PDT. These efforts, which are summarized in this review, have produced many innovative methods to avoid the limits of PDT associated with hypoxia.

Keywords: hypoxia; oxygen delivery; photodynamic therapy; tumors.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Humans
  • Neoplasms / blood supply
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Oxygen / metabolism
  • Photochemotherapy / methods*
  • Photosensitizing Agents / chemistry
  • Photosensitizing Agents / pharmacology
  • Photosensitizing Agents / therapeutic use*
  • Tumor Hypoxia / drug effects*
  • Tumor Microenvironment / drug effects

Substances

  • Photosensitizing Agents
  • Oxygen